MedTrace Logo

Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions

NCT06643507 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2026-03-20

No results posted yet for this study

Summary

treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF

Conditions

  • Gingival Recession

Interventions

OTHER

Connective tissue graft

regenerative properties

BIOLOGICAL

ALB-PRF

regenerative properties

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Enji EA Ahmed, BDS.MDS.PHD · Cairo University

  • Sarah SE Elbanna, BDS.MDS.PHD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-20
Primary Completion
2026-12-20
Completion
2027-01-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06643507 on ClinicalTrials.gov